Richard Shelby actually said...

"As research becomes more expensive and private capital dries up, I believe it's critical to ensure support for translational research."

"We would all benefit from that, wouldn't we?"

"It seems like that's an ideal opportunity for academia to team with industry to bring treatments to patients faster."

"Oh, quite intensively."